| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Viral vector |
| Clinical data | |
| Routes of administration | Intranasal |
| Part ofa series on the |
| COVID-19 pandemic |
|---|
|
Medical response |
|
INNA-051 is aCOVID-19 vaccine candidate developed by Ena Respiratory.[1][2]
This article about COVID-19 vaccines is astub. You can help Wikipedia byexpanding it. |
This article aboutvaccines orvaccination is astub. You can help Wikipedia byexpanding it. |